Male Breast Cancer Active Not Recruiting Phase 2 Trials for Sargramostim (DB00020)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00343109Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast CancerPrevention